CHRISTINE HWANG: Open Payments
NPI 1982090114 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,373 in 137 payments from 18 companies in 2025. Trend: 2023 $408 · 2024 $1,977 · 2025 $3,373
Food & beverage: $3,274Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $759 |
| PFIZER INC. | 17 | $545 |
| GENZYME CORPORATION | 14 | $353 |
| UCB, Inc. | 16 | $351 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $204 |
| Amgen Inc. | 9 | $187 |
| Incyte Corporation | 12 | $172 |
| Arcutis Biotherapeutics, Inc. | 8 | $165 |
| Eli Lilly and Company | 1 | $99 |
| Galderma Laboratories, L.P. | 4 | $96 |
Products named: SKYRIZI, CIBINQO, DUPIXENT, Bimzelx, RINVOQ, ILUMYA, OTEZLA, Zoryve.
Industry payments across WA — which companies pay providers there.
